Table 2. Comparison of the efficacy of the treatment of rotator cuff tendinopathy—platelet-rich plasma versus corticoid.
| Tratament received | ||||
|---|---|---|---|---|
| PRP | Corticoid | CI 95% | p -score | |
| DASH outcome | ||||
| Admission | 53.3 | 54.5 | [-52.9; 21.35] | 0.135 |
| 1 month | 32.5 | 22.9 | [-37.01; -0.85] | 0.205 |
| 3 months | 23.5 | 20.2 | [-104.76; 44.08] | 0.235 |
| 6 months | 21.6 | 17.7 | [-14.14; 18.57] | 0.824 |
| UCLA shoulder rating scale | ||||
| Admission | 13.4 | 14.9 | [-3,.02; 6.19] | 0.926 |
| 1 month | 23 | 23.9 | [-4.45; 6.07] | 0.832 |
| 3 months | 29.3 | 29.6 | [-9.54; 10.16] | 0.898 |
| 6 months | 27 | 27.6 | [-8.53; 9.73] | 0.005 |
| Constant shoulder score | ||||
| Admission | 45.9 | 49.8 | [-5.04; 12.80] | 0.049 |
| 1 month | 55.4 | 58.8 | [-4.43; 11.12] | 0.503 |
| 3 months | 59.8 | 68 | [-5.39; 21.74] | 0.848 |
| 6 months | 62.9 | 56.9 | [-21.45; 9.42] | 0.228 |
Abbreviations: CI, confidence interval; DASH, Disabilities of the Arm, Shoulder and Hand; PRP, platelet-rich plasma; UCLA, University of California Los Angeles.